Adherence to Adalimumab Was Not Improved by a Reminder-Based Intervention with an Electronic Needle Container

J Schultheiss(University Medical Center Utrecht), Herma H. Fidder(University Medical Center Utrecht), Max R. Clevers(Heidelberg University), Sandra Altena(Heidelberg University), Dominique Baas(Université Claude Bernard Lyon 1), Bindia Jharap(Meander Medisch Centrum)
Digestive Diseases and Sciences
June 16, 2020
10.1007/s10620-020-06395-z
Cited by 10

Related Papers

Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management
|Clinical and Translational Gastroenterology|2016|724
Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice
|Gut|2019|221
Thiopurine therapy in inflammatory bowel disease patients: Analyses of two 8-year intercept cohorts
|Inflammatory Bowel Diseases|2010|199
Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease
|Gut|2013|144
Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD
|Nature Clinical Practice Gastroenterology &#38 Hepatology|2007|129